fluorodeoxyglucose f18 has been researched along with Adrenal Cortex Cancer in 51 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (1.96) | 18.2507 |
| 2000's | 14 (27.45) | 29.6817 |
| 2010's | 23 (45.10) | 24.3611 |
| 2020's | 13 (25.49) | 2.80 |
| Authors | Studies |
|---|---|
| Chae, Y; Chang, D; Kang, BT; Kim, H; Koo, Y; Lee, D; Yang, MP; Yun, T | 1 |
| Cunha, C; Donato, S; Leite, V; Silva, T | 1 |
| Chen, X; Fan, Y; Li, Q; Tong, Z; Zhang, J | 1 |
| Hahner, S; Hartrampf, PE; Schirbel, A; Werner, RA | 1 |
| Barletta, JA; Doherty, GM; Jacene, HA; Kilbridge, KL; Moore, AL; Nehs, MA; Shah, HJ; Vaidya, A; Wrenn, SM | 1 |
| Cavaco, D; Donato, S; Fraga, D; Maciel, J; Simões, H; Simões-Pereira, J; Sousa, R | 1 |
| Chatterjee, D; Chopra, S; Kumar, R; Mittal, BR; Pandey, S; Rana, N; Satz, S; Shukla, J; Walia, R | 1 |
| Chatterji, D; Chopra, S; Kumar, R; Mathur, Y; Mittal, BR; Moon, ES; Pandey, S; Rana, N; Roesch, F; Shukla, J; Singh, H; Walia, R | 1 |
| Can, C; Güzel, Y; Ibiloğlu, İ; Kaplan, İ; Kepenek, F | 1 |
| Assié, G; Barat, M; Bertherat, J; Bonnet, F; Coste, J; Cottereau, AS; Dohan, A; Dousset, B; Gaillard, M; Gaujoux, S; Groussin, L; Guignat, L; Huillard, O; Libé, R; Pais, A; Sibony, M; Tenenbaum, F; Violon, F | 1 |
| Chen, H; Dai, J; Gao, F; Tian, R | 1 |
| Baba, S; Hida, T; Honda, H; Inokuchi, J; Murayama, R; Nishie, A; Oda, Y | 1 |
| Beuschlein, F; Bluemel, C; Fassnacht, M; Hahner, S; Loewe, R; Pfluger, T; Reincke, M; Rogowski-Lehmann, N | 1 |
| Deguchi-Horiuchi, H; Fujimoto, M; Ichikawa, T; Igarashi, K; Ikeda, JI; Imamura, Y; Ishida, A; Ishiwata, K; Koide, H; Naito, K; Ruike, Y; Sakamoto, S; Suzuki, S; Yokote, K | 1 |
| Chen, H; Fu, H; Guo, X; Wu, H | 1 |
| Dantes, M; Eze, C; Manapov, F; Pazos-Escudero, M; Roengvoraphoj, O | 1 |
| Aggarwal, S; Arora, G; Arora, S; Bal, C; Behera, A; Damle, NA; Passah, A; Tripathi, M | 1 |
| Groussin, L; Jazeron, JF; Libé, R; Louiset, E | 1 |
| Fukawa, T; Fukumori, T; Izaki, H; Kanayama, HO; Komori, M; Nakatsuji, H; Senzaki, T; Takahashi, M; Takemura, M; Yamaguchi, K; Yamamoto, Y | 1 |
| Ahn, BC; Jang, YJ; Jeong, SY; Lee, J; Lee, SW; Park, JY; Son, SH; Song, BI | 1 |
| Assié, G; Libé, R | 1 |
| Brumberg, J; Higuchi, T; Lapa, C; Werner, RA | 1 |
| Balachandran, A; Bassett, RL; Chuang, HH; Habra, MA; Macapinlac, HA; Phan, AT; Takeuchi, S | 1 |
| Arai, Y; Fujishima, F; Ise, K; Kasajima, A; Morimoto, R; Nakamura, Y; Omata, K; Ono, Y; Sasano, H; Sato, N; Satoh, F; Takanami, K; Watanabe, M; Yamada, S | 1 |
| Dieckmann, W; Kebebew, E; Nilubol, N; Patel, D; Satoh, K | 1 |
| Ardito, A; Arena, V; Basile, V; Brambilla, R; Duregon, E; Massaglia, C; Pelosi, E; Penna, D; Perotti, P; Terzolo, M; Vigna-Taglianti, F; Zaggia, B | 1 |
| Bluemel, C; Buck, AK; Bundschuh, RA; Fassnacht, M; Hahner, S; Higuchi, T; Kroiss, M; Lapa, C; Mügge, DO; Nakajo, M; Papp, L; Schirbel, A; Werner, RA; Zsótér, N | 1 |
| Harada, Y; Miyazaki, S | 1 |
| Charalampopoulos, A; Farrugia, FA; Martikos, G; Misiakos, E; Surgeon, C; Tzanetis, P; Zavras, N | 1 |
| Chung, JJ; Hong, SW; Kim, DJ; Kim, JH; Ryu, YH; Yu, JS | 1 |
| Abiven, G; Alberini, JL; Bertagna, X; Bertherat, J; Bienvenu, M; Bonardel, G; Bouchard, P; Coste, J; Dousset, B; Foehrenbach, H; Groussin, L; Legmann, P; Libé, R; Richard, B; Salenave, S; Silvéra, S; Tenenbaum, F; Tissier, F | 1 |
| Tenenbaum, F | 1 |
| Andersen, KF; Hendel, HW; Mellemgaard, A | 1 |
| Bertagna, X; Bienvenu, M; Dousset, B; Faraggi, M; Groussin, L; Hignette, C; Joannidis, S; Legmann, P; Libé, R; Richard, B; Tenenbaum, F; Tissier, F | 1 |
| Belleannee, G; Gaye, D; Guyot, M; Nunes, ML; Rault, A; Tabarin, A; Teynie, J; Valli, N | 1 |
| Al Ghuzlan, A; Aupérin, A; Baudin, E; Bidault, F; Deandreis, D; Escourrou, C; Leboulleux, S; Lumbroso, J; Schlumberger, M; Travagli, JP | 1 |
| Barlier, A; Beliard, A; de Micco, C; Gust, L; Henry, JF; Morange, I; Sebag, F; Taieb, D | 1 |
| Bhansali, A; Bhattacharya, A; Kashyap, R; Mittal, BR; Radotra, BD; Senthil, R | 1 |
| Bertagna, X; Bertherat, J; Dousset, B; Ghander, C; Groussin, L; Legmann, P; Ragazzon, B; Richard, B; Silvera, S; Tenenbaum, F; Tissier, F | 1 |
| Chuang, HH; Deniz, F; Habra, MA; Jimenez, C; Rubin De Celis, C; Sircar, K; Wood, CG | 1 |
| Ansquer, C; Bournaud, C; de la Foucardère, C; Drui, D; Lifante, JC; Mancini, J; Mirallié, E; Morange, I; Palazzo, FF; Sebag, F; Taïeb, D; Tessonnier, L | 1 |
| Ahmed, M; Al-Sobhi, S; Al-Sugair, A; Alarifi, A; Almahfouz, A | 1 |
| Aoki, J; Endo, K; Higuchi, T; Oriuchi, N; Shimizu, A; Tsushima, Y | 1 |
| Caride, VJ; Giakovis, E; Lee, SH; Ponn, R; Rao, SK | 1 |
| Bertagna, X; Bertherat, J; Dousset, B; Foehrenbach, H; Gouya, H; Groussin, L; Legmann, P; Richard, B; Tenenbaum, F; Tissier, F | 1 |
| Aupérin, A; Baudin, E; Bonniaud, G; Caillou, B; Dromain, C; Leboulleux, S; Lumbroso, J; Schlumberger, M; Sigal, R | 1 |
| Connolly, LP; Gauger, PG; Hurwitz, CA; Kunter, G; Mackie, GC; Mody, RJ; Ribeiro, RC; Rodriguez-Galindo, C; Schteingart, DE; Shulkin, BL; Wallis, JW; Worden, FP | 1 |
| Hallfeldt, K; Mueller-Lisse, U; Pfluger, T; Reincke, M; Schlamp, A | 1 |
| Cheng, MF; Tzen, KY; Wu, YW; Yen, RF | 1 |
| Brink, I; Moser, E; Nitzsche, EU; Schumacher, T | 1 |
| Becherer, A; Dudczak, R; Karanikas, G; Kletter, K; Kurtaran, A; Pötzi, C; Schmaljohann, J; Staudenherz, A; Vierhapper, H | 1 |
5 review(s) available for fluorodeoxyglucose f18 and Adrenal Cortex Cancer
| Article | Year |
|---|---|
Adrenal functional imaging - which marker for which indication?
Topics: 3-Iodobenzylguanidine; Adrenal Cortex Neoplasms; Adrenal Gland Neoplasms; Biomarkers; Fluorodeoxyglucose F18; Glucose Transport Proteins, Facilitative; Humans; Norepinephrine Plasma Membrane Transport Proteins; Paraganglioma; Pheochromocytoma; Positron-Emission Tomography; Radiopharmaceuticals; Receptors, Chemokine; Receptors, Somatostatin | 2022 |
[Adrenocortical carcinoma: Update in 2014].
Topics: Adrenal Cortex Hormones; Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Adenoma; Biomarkers, Tumor; Combined Modality Therapy; Disease Progression; Female; Fluorodeoxyglucose F18; Gene Expression Profiling; Genetic Predisposition to Disease; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Prognosis; Survival Rate; Tomography, X-Ray Computed | 2014 |
Radiology of the adrenal incidentalomas. Review of the literature.
Topics: 3-Iodobenzylguanidine; Addison Disease; Adrenal Cortex Neoplasms; Adrenal Gland Diseases; Adrenal Gland Neoplasms; Adrenocortical Adenoma; Adrenocortical Carcinoma; Cushing Syndrome; Diffusion Magnetic Resonance Imaging; Fluorodeoxyglucose F18; Hemorrhage; Humans; Hyperaldosteronism; Indium; Indium Radioisotopes; Lymphoma; Magnetic Resonance Imaging; Myelolipoma; Octreotide; Pheochromocytoma; Positron-Emission Tomography; Radionuclide Imaging; Radiopharmaceuticals; Tomography, X-Ray Computed; Ultrasonography | 2017 |
Adrenocortical oncocytoma displaying intense activity on 18F-FDG-PET: a case report and a literature review.
Topics: Adenoma, Oxyphilic; Adrenal Cortex Neoplasms; Aged; Female; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Radiopharmaceuticals | 2008 |
[Adrenal incidentaloma and nuclear medicine examination].
Topics: 19-Iodocholesterol; 3-Iodobenzylguanidine; Adenoma; Adrenal Cortex Neoplasms; Adrenal Gland Neoplasms; Adult; Dihydroxyphenylalanine; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Incidental Findings; Pheochromocytoma; Positron-Emission Tomography; Radiopharmaceuticals | 2009 |
46 other study(ies) available for fluorodeoxyglucose f18 and Adrenal Cortex Cancer
| Article | Year |
|---|---|
18F-FDG PET/CT image findings of a dog with adrenocortical carcinoma.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Animals; Dog Diseases; Dogs; Fluorodeoxyglucose F18; Male; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Tomography, X-Ray Computed | 2022 |
Functioning metastasis from adrenocortical carcinoma.
Topics: Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Adenoma; Adrenocortical Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron-Emission Tomography | 2022 |
18 F-FDG PET/CT Findings in a Patient With Primary Prostatic Synovial Sarcoma Combined With Adrenocortical Carcinoma.
Topics: Adrenal Cortex Neoplasms; Adrenal Gland Neoplasms; Adrenocortical Carcinoma; Adult; Fluorodeoxyglucose F18; Humans; Male; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prostatic Neoplasms; Sarcoma, Synovial | 2022 |
Higher SUV
Topics: Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Fluorodeoxyglucose F18; Glucose; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies | 2023 |
Adrenal findings in FDG-PET: analysis of a cohort of 1021 patients from a cancer center.
Topics: Adrenal Cortex Neoplasms; Adrenal Gland Neoplasms; Adrenocortical Carcinoma; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2023 |
68Ga-DOTAGA-IAC PET/CT for Imaging Metastatic and Recurrent Adrenocortical Carcinoma: A Case Series.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2023 |
68 Ga-DOTA.SA.FAPI as a Potential, Noninvasive Diagnostic Probe for Recurrent and Metastatic Adrenocortical Carcinoma : A Head-to-Head Comparison With 18F-FDG.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography | 2023 |
Superiority of 18 F-FDG PET/CT to 68 GA-FAPI PET/CT in Adrenocortical Tumor Imaging.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Female; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Middle Aged; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2023 |
Positive Correlation Between 18 F-FDG Uptake and Tumor-Proliferating Antigen Ki-67 Expression in Adrenocortical Carcinomas.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Cohort Studies; Fluorodeoxyglucose F18; Humans; Ki-67 Antigen; Positron-Emission Tomography; Radiopharmaceuticals | 2023 |
Right Adrenocortical Carcinoma Coexisting With Left Adrenal Sarcomatoid Carcinoma on FDG PET/CT.
Topics: Adrenal Cortex Neoplasms; Adrenal Glands; Adrenocortical Carcinoma; Aged, 80 and over; Fluorodeoxyglucose F18; Humans; Male; Positron Emission Tomography Computed Tomography; Sarcoma; Soft Tissue Neoplasms | 2023 |
Uptake of 18F-FDG in Adrenal Adenomas Is Associated With Unenhanced CT Value and Constituent Cells.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Adult; Aged; Aged, 80 and over; Biological Transport; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Retrospective Studies; Tomography, X-Ray Computed | 2019 |
Predicitve Value of FDG Uptake in the Remaining Adrenal Gland Following Adrenalectomy for Adrenocortical Cancer.
Topics: Adrenal Cortex Neoplasms; Adrenal Glands; Adrenalectomy; Adrenocortical Carcinoma; Adult; Aged; Aged, 80 and over; Cohort Studies; Female; Fluorodeoxyglucose F18; Humans; Liver; Male; Mediastinum; Middle Aged; Mitotane; Predictive Value of Tests; Survival Analysis; Time Factors | 2021 |
Characteristics of benign adrenocortical adenomas with 18F-FDG PET accumulation.
Topics: Adolescent; Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Adult; Aged; Cohort Studies; Female; Fluorodeoxyglucose F18; Humans; Hydrocortisone; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; RNA-Seq; Tomography, X-Ray Computed; Transcriptome; Tumor Burden; Young Adult | 2021 |
Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome Combined With Adrenocortical Carcinoma on 18F-FDG PET/CT.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Leiomyomatosis; Neoplastic Syndromes, Hereditary; Positron Emission Tomography Computed Tomography; Skin Neoplasms; Uterine Neoplasms; Young Adult | 2017 |
18FDG-PET/CT for the Visualization of Inflammatory Component of Radiation-Induced Lung Injury After Stereotactic Radiotherapy.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Lung Injury; Middle Aged; Positron Emission Tomography Computed Tomography; Radiation Injuries; Radiosurgery | 2018 |
Prostate-Specific Membrane Antigen Expression in Adrenocortical Carcinoma on 68Ga-Prostate-Specific Membrane Antigen PET/CT.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Adult; Edetic Acid; Fluorodeoxyglucose F18; Gallium Isotopes; Gallium Radioisotopes; Humans; Lung Neoplasms; Male; Oligopeptides; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2018 |
18F-FDG PET reveals an adrenocortical carcinoma in a bilateral adrenal multinodular disease.
Topics: Adrenal Cortex Diseases; Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Carcinoma; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2019 |
[Adrenal cortical adenoma with increased uptake of 18F-fluoro-deoxy-glucose on PET/CT suspected as an adrenal metastasis from the cervical cancer : a case report].
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2013 |
Recurrence of a functional adrenocortical oncocytoma of borderline malignant potential showing high FDG uptake on 18F-FDG PET/CT.
Topics: Adenoma, Oxyphilic; Adrenal Cortex Neoplasms; Biological Transport; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Recurrence; Tomography, X-Ray Computed | 2014 |
Preoperative FDG PET/CT in adrenocortical cancer depicts massive venous tumor invasion.
Topics: Adrenal Cortex Neoplasms; Aged; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Invasiveness; Positron-Emission Tomography; Preoperative Care; Renal Veins; Tomography, X-Ray Computed; Ultrasonography | 2014 |
Impact of ¹⁸F-FDG PET/CT on the management of adrenocortical carcinoma: analysis of 106 patients.
Topics: Adolescent; Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Adult; Aged; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Young Adult | 2014 |
Case report: adrenal oncocytoma associated with markedly increased FDG uptake and immunohistochemically positive for GLUT1.
Topics: Adenoma, Oxyphilic; Adrenal Cortex Neoplasms; Adult; Female; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Humans; Immunohistochemistry; Microscopy, Electron; Positron-Emission Tomography; Radiopharmaceuticals | 2014 |
Whole Body Metabolic Tumor Volume and Total Lesion Glycolysis Predict Survival in Patients with Adrenocortical Carcinoma.
Topics: Adolescent; Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Adult; Aged; Bone Neoplasms; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glycolysis; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Retrospective Studies; Survival Rate; Tissue Distribution; Tomography, X-Ray Computed; Tumor Burden; Whole Body Imaging; Young Adult | 2015 |
18F-FDG PET/CT in the post-operative monitoring of patients with adrenocortical carcinoma.
Topics: Abdominal Neoplasms; Adolescent; Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Carcinoma; Adult; Aged; Cohort Studies; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Postoperative Period; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Young Adult | 2015 |
Assessment of tumor heterogeneity in treatment-naïve adrenocortical cancer patients using (18)F-FDG positron emission tomography.
Topics: Adolescent; Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Tumor Burden; Young Adult | 2016 |
Adrenocortical Carcinoma Treated by CyberKnife.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Radiosurgery; Tomography, Emission-Computed; Treatment Outcome | 2016 |
18F-Fluorodeoxyglucose positron emission tomography for the diagnosis of adrenocortical tumors: a prospective study in 77 operated patients.
Topics: Adrenal Cortex Neoplasms; Adult; Aged; Blood Glucose; Diabetes Complications; Female; Fluorodeoxyglucose F18; Hormones; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Paris; Positron-Emission Tomography; Preoperative Care; Prospective Studies; Tomography, X-Ray Computed | 2009 |
Multimodality imaging in a patient with adrenocortical carcinoma leading to peptide receptor radionuclide therapy.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Adult; Diagnostic Imaging; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Staging; Receptors, Peptide | 2009 |
Adrenocortical tumor with two distinct elements revealed by combined (18)F-fluorodeoxyglucose positron emission tomography and (131)I nor-cholesterol scintigraphy.
Topics: Adenoma; Adosterol; Adrenal Cortex Neoplasms; Aged; Carcinoma; Cushing Syndrome; Female; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals | 2009 |
18F-FDG PET for the identification of adrenocortical carcinomas among indeterminate adrenal tumors at computed tomography scanning.
Topics: Adrenal Cortex Neoplasms; Adrenal Gland Neoplasms; Adrenocortical Adenoma; Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2010 |
Fluorodesoxyglucose uptake in the remaining adrenal glands during the follow-up of patients with adrenocortical carcinoma: do not consider it as malignancy.
Topics: Adrenal Cortex Neoplasms; Adrenal Glands; Adrenalectomy; Adrenocortical Carcinoma; Adult; Aged; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Pheochromocytoma; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Time Factors | 2011 |
Preoperative 18F-FDG uptake is strongly correlated with malignancy, Weiss score, and molecular markers of aggressiveness in adrenal cortical tumors.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Positron-Emission Tomography; Preoperative Care; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity | 2012 |
¹⁸F FDG PET/CT demonstration of IVC and right atrial involvement in adrenocortical carcinoma.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Adult; Female; Fluorodeoxyglucose F18; Heart Atria; Humans; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Vena Cava, Inferior | 2012 |
A concomitant false-negative ¹⁸F-FDG PET imaging in an adrenocortical carcinoma and a high uptake in a corresponding liver metastasis.
Topics: 19-Iodocholesterol; Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; False Negative Reactions; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Liver Neoplasms; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Tissue Distribution | 2012 |
[¹⁸F]Fluorodeoxyglucose positron emission tomography-guided therapy in metastatic adrenocortical carcinoma: an illustrative case.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Fluorodeoxyglucose F18; Humans; Male; Neoadjuvant Therapy; Neoplasm Metastasis; Positron-Emission Tomography | 2012 |
(18)F-FDG uptake at initial staging of the adrenocortical cancers: a diagnostic tool but not of prognostic value.
Topics: Adrenal Cortex Neoplasms; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Young Adult | 2013 |
Whole-body positron emission tomographic scanning in patients with adrenal cortical carcinoma: comparison with conventional imaging procedures.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Adult; Cushing Syndrome; Fluorodeoxyglucose F18; Humans; Male; Radiopharmaceuticals; Tomography, Emission-Computed | 2003 |
High [18F] 2-fluoro-2-deoxy-D-glucose (FDG) uptake of adrenocortical adenoma showing subclinical Cushing's syndrome.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Adrenocorticotropic Hormone; Cushing Syndrome; Female; Fluorodeoxyglucose F18; Humans; Hydrocortisone; Incidental Findings; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals | 2003 |
F-18 fluorodeoxyglucose positron emission tomography-positive benign adrenal cortical adenoma: imaging features and pathologic correlation.
Topics: Adrenal Cortex; Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Aged; Female; Fluorodeoxyglucose F18; Humans; Radiopharmaceuticals; Tomography, Emission-Computed | 2004 |
18F-fluorodeoxyglucose positron emission tomography as a diagnostic tool for malignancy of adrenocortical tumours? Preliminary results in 13 consecutive patients.
Topics: Adrenal Cortex; Adrenal Cortex Neoplasms; Adult; Female; Fluorodeoxyglucose F18; History, 18th Century; Humans; Liver; Liver Neoplasms; Male; Middle Aged; Neoplasm Staging; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2004 |
Diagnostic and prognostic value of 18-fluorodeoxyglucose positron emission tomography in adrenocortical carcinoma: a prospective comparison with computed tomography.
Topics: Adrenal Cortex Neoplasms; Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Survival Analysis; Tomography, X-Ray Computed | 2006 |
Use of [18F]fluorodeoxyglucose positron emission tomography in evaluating locally recurrent and metastatic adrenocortical carcinoma.
Topics: Adrenal Cortex Neoplasms; Adult; Aged; Child; Child, Preschool; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron-Emission Tomography | 2006 |
Recurrent adrenocortical carcinoma after laparoscopic resection.
Topics: Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Carcinoma; Fluorodeoxyglucose F18; Humans; Laparoscopy; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Treatment Outcome | 2007 |
F-18 FDG PET/CT illustrating tumor invasion in the IVC from adrenocortical carcinoma.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Invasiveness; Positron-Emission Tomography; Tomography, X-Ray Computed; Vena Cava, Inferior | 2007 |
[Imaging of an adrenal cortex carcinoma and its metastasis with FDG-PET].
Topics: Adrenal Cortex Neoplasms; Adult; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Neoplasm Recurrence, Local; Radiopharmaceuticals; Time Factors; Tomography, Emission-Computed | 1999 |
FDG-PET in adrenocortical carcinoma.
Topics: Abdominal Neoplasms; Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Adult; Aged; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Prospective Studies; Radiopharmaceuticals; Tomography, Emission-Computed | 2001 |